Carisma Therapeutics Inc. (CARM)
0.40
-0.00 (-0.25%)
At close: Mar 03, 2025, 3:59 PM
0.42
3.94%
After-hours: Mar 03, 2025, 05:30 PM EST
Carisma Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -86.88M | -61.23M | -40.78M | -28.35M | -107.5M | -33.69M | -29.03M | 1.89M | -33.45M | -34.16M | -18.02M | -19.66M | -12.83M |
| Depreciation & Amortization | 2.84M | 6.09M | 682K | 448K | 219K | 208K | 285K | 178K | 366K | 410K | 438K | 448K | 364K |
| Stock-Based Compensation | 2.32M | 275K | 479K | 163K | n/a | n/a | 1.38M | 4.01M | 2.53M | 2.43M | 1.26M | 130K | 38K |
| Other Working Capital | -7.63M | 45.67M | 2.44M | -1.74M | -3.63M | 118K | 1.37M | -1.73M | 236K | 92K | 1.87M | -134K | 911K |
| Other Non-Cash Items | 5.99M | -19.65M | 834K | 1.18M | 72.76M | 10.03M | 11.7M | 4.12M | 1.48M | 894K | 1.18M | 71K | 12K |
| Deferred Income Tax | n/a | 21.75M | n/a | n/a | -1.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -5.44M | 45.2M | 1.46M | -453K | -3.1M | 578K | 611K | -2.47M | -976K | 1.11M | 1.66M | -84K | 1.54M |
| Operating Cash Flow | -81.18M | -7.57M | -37.33M | -27.01M | -37.52M | -22.83M | -17.77M | 2.62M | -34.53M | -29.31M | -13.49M | -19.09M | -10.87M |
| Capital Expenditures | -1.13M | -4.66M | -1.87M | -440K | -136K | -2K | n/a | n/a | -287K | -137K | n/a | -110K | -805K |
| Acquisitions | n/a | 30K | n/a | n/a | n/a | n/a | 98K | 461K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -34.46M | -90.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 108M | 63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -30K | n/a | n/a | n/a | n/a | 98K | 461K | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 72.41M | -32.56M | -1.87M | -440K | -136K | -2K | 98K | 461K | -287K | -137K | n/a | -110K | -805K |
| Debt Repayment | -1.3M | 34.13M | n/a | n/a | n/a | n/a | n/a | -14.12M | 4.12M | 5.25M | 4.69M | 992K | -583K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -2K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 32.24M | -35.92M | 15.96M | 72.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 62.18M | 35.77M | 15.96M | 72.26M | 35.36M | 58.58M | 7M | -13.82M | 16.84M | 75.56M | 13.55M | 26.38M | 10.45M |
| Net Cash Flow | 53.41M | -138.44M | -23.24M | 44.81M | -2.3M | 35.74M | -10.66M | -10.74M | -17.98M | 46.12M | 60K | 7.18M | -1.23M |
| Free Cash Flow | -82.31M | -12.23M | -39.2M | -27.45M | -37.66M | -22.83M | -17.77M | 2.62M | -34.82M | -29.44M | -13.49M | -19.2M | -11.67M |